UNSPSC 51281679: Viomycin hydrochloride

This classification denotes the hydrochloride form of an antitubercular agent with the molecular structure C25H43N13O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, YVU35998K5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)-, but more commonly known as viomycin, which bears US NIH Compound Identifier 3032902.

UNSPSC 51281679 Viomycin hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local opportunities posted under this code do not involve viomycin hydrochloride itself. Instead, the record shows Illinois Department of Public Health awarding a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, and Seminole County, Florida issuing an IFB for Naloxone and Safe Drug Deactivation Systems. The code exhibits minimal alignment with its stated commodity name, indicating either a data-entry mismatch in the underlying procurement systems or incidental tagging of unrelated pharmaceutical products under this code number.

The geographic activity appears concentrated in Florida and Illinois based on recent postings. The issuing bodies include a state health department and a county government. No active open solicitations under this code are currently posted; the Illinois award to Chartwell Rx LLC closed on September 11, 2026, and the Seminole County IFB closed on July 26, 2023. Given the apparent disconnect between the code's nominal scope and the work actually being tagged to it in state and local procurement systems, this code shows little decision-relevant activity for vendors focused on viomycin hydrochloride procurement.